AlmaLab: among the top 5 best Medicinal Cannabis brands in Brazil

Well-being, quality, and lightness. These are some of the adjectives that define AlmaLab, a company that stands out in the medicinal cannabis market and prioritizes offering high-quality products to its patients, developed under rigorous scientific and technological standards. Because of this, this week, it was ranked 5th among the best brands specializing in cannabis-based products in the Journal of Cannabis Research survey, which evaluates the quality of cannabidiol oils in Brazil!

"This recognition reinforces our commitment to excellence, ingredient purity, and the well-being of our customers. We are very happy to be part of this select ranking, and of course, this was only possible thanks to the trust and support of each person with us," celebrated Thaise Alvarez, CEO of AlmaLAB.

Market positioning 

AlmaLAb is one of the sponsoring companies of the Brazilian Medicinal Cannabis Congress 2025 (CBCM), and reinforces its mission to expand access to cannabinoid therapy and disseminate knowledge about its benefits.

According to Thaise, the brand goes beyond the production of cannabis derivatives: "More than a brand based on the development of natural products, AlmaLAB aims to deliver positive experiences to people, promoting balance between mind, body, and soul," she pointed out.

This philosophy is reflected in a product line that prioritizes organic ingredients and natural supplements, ensuring lightness and smoothness in the consumer experience.

AlmaLAB: education and patient support

In addition to product development, the company strongly invests in disseminating scientific knowledge about cannabis. "We believe that knowledge transforms lives, therefore, we focus on a journey of continuous education, offering support to healthcare professionals and the general public with information based on scientific evidence," argued Thaise.

To ensure that patients use the products safely and effectively, the company has AlmaCare service, a specialized monitoring sector where a nursing team follows the entire treatment.

Medicinal cannabis: quality and future challenges

The medicinal cannabis sector demands high standards of control and efficacy, and AlmaLab stands out in this regard. The company maintains strategic partnerships with renowned laboratories in the United States and Italy, ensuring a high level of quality in its products. 

Despite regulatory advances, the medicinal cannabis market in Brazil still faces significant obstacles. Thaise, who started her journey in the sector in 2020, points out that one of the main challenges was the slowness in the ANVISA authorization processes, hindering quick access to medications. In addition, the lack of a more robust regulation brought barriers to sector growth.

However, the CEO sees a promising future: "Brazil has the potential to achieve significant sales figures by 2025. I believe in even greater growth, as more and more healthcare professionals seek this therapy for their clinical treatments," she said.

She also advocates the need to facilitate product manipulation within the country, reducing costs and delivery times for patients.

Brazilian Medicinal Cannabis Congress 2025

Official sponsor of CBCM since its first edition, AlmaLab sees the event as an essential opportunity to strengthen the sector. "Our commitment goes beyond product quality; we believe in the importance of fostering the market, disseminating scientific information, and positioning AlmaLab always at the forefront, bringing innovation and reliability," she states.

With an innovative vision and a continuous commitment to excellence, AlmaLab consolidates itself as a reference in the sector, promoting quality of life and revolutionizing access to medicinal cannabis in Brazil.